Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IVF hartmann Holding AGXSWX:VBSN +1.92%74 Cyclically Adjusted PS Ratio is 2.04 as of Jul. 16, 2026, which is 26% below its 10-year median of 2.77. GuruFocus rates XSWX:VBSN with a GF Score™ of 74/100 and a GF Value™ of CHF143.29 (Fairly Valued). Among 523 Medical Devices & Instruments companies, IVF hartmann Holding AG ranks better than 52.39% on this metric.
The historical rank and industry rank for IVF hartmann Holding AG's Cyclically Adjusted PS Ratio or its related term are showing as below:
XSWX:VBSN'
s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.66 Med: 2.77 Max: 4.37
Current: 2.07
During the past 13 years, IVF hartmann Holding AG's highest Cyclically Adjusted PS Ratio was 4.37. The lowest was 1.66. And the median was 2.77.
XSWX:VBSN's Cyclically Adjusted PS Ratio is ranked better than 52.39% of 523
companies
in the Medical Devices & Instruments industry
Industry Median: 2.28
vs XSWX:VBSN: 2.07
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
IVF hartmann Holding AG's adjusted revenue per share data of for the fiscal year that ended in Dec25 was CHF67.334. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is CHF64.01 for the trailing ten years ended in Dec25.
Shiller PE for Stocks: The True Measure of Stock Valuation
IVF hartmann Holding AG (XSWX:VBSN) Cyclically Adjusted PS Ratio Explanation
Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.
IVF hartmann Holding AG Cyclically Adjusted PS Ratio Related Terms
IVF hartmann Holding AG Cyclically Adjusted PS Ratio Historical Data
* Premium members only.
The historical data trend for IVF hartmann Holding AG's Cyclically Adjusted PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IVF hartmann Holding AG Cyclically Adjusted PS Ratio Chart
XSWX:VBSN vs ISRG, BDX, MDLN: Cyclically Adjusted PS Ratio Comparison
For the Medical Instruments & Supplies subindustry, IVF hartmann Holding AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IVF hartmann Holding AG Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, IVF hartmann Holding AG's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where IVF hartmann Holding AG's Cyclically Adjusted PS Ratio falls into.
IVF hartmann Holding AG Cyclically Adjusted PS Ratio Calculation
Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
What does a Cyclically Adjusted PS Ratio of 2.04 mean?
IVF hartmann Holding AG (XSWX:VBSN) has a Cyclically Adjusted PS Ratio of 2.04 as of Jul. 16, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on IVF hartmann Holding AG and its competitors. This is 26% below median its historical median of 2.77. Over the past decade, IVF hartmann Holding AG's Cyclically Adjusted PS Ratio has ranged from 1.66 to 4.37. According to the industry distribution chart, IVF hartmann Holding AG ranks #249 out of 523 companies in the Medical Devices & Instruments industry, placing it in the top 47.6%.
Is IVF hartmann Holding AG's Cyclically Adjusted PS Ratio too high?
IVF hartmann Holding AG's current Cyclically Adjusted PS Ratio of 2.04 is 26% below median its 10-year median of 2.77. Over the past 10 years, this metric has ranged from a low of 1.66 to a high of 4.37. The Medical Devices & Instruments industry median Cyclically Adjusted PS Ratio is 2.28. IVF hartmann Holding AG's value of 2.04 is 10.5% below this industry median. Based on the distribution chart, IVF hartmann Holding AG ranks #249 out of 523 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, IVF hartmann Holding AG has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IVF hartmann Holding AG's Cyclically Adjusted PS Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, IVF hartmann Holding AG ranks #249 out of 523 companies for Cyclically Adjusted PS Ratio. This puts IVF hartmann Holding AG in the upper half of its industry. The industry median Cyclically Adjusted PS Ratio is 2.28. IVF hartmann Holding AG's value of 2.04 is 10.5% below this benchmark. Historically, IVF hartmann Holding AG's own Cyclically Adjusted PS Ratio has ranged from 1.66 to 4.37 over the past decade. While the company's 10-year median is 2.77 vs. the industry median of 2.28, IVF hartmann Holding AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Medical Devices & Instruments company?
The median Cyclically Adjusted PS Ratio among Medical Devices & Instruments companies is 2.28, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IVF hartmann Holding AG's current Cyclically Adjusted PS Ratio of 2.04 is 10.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on IVF hartmann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Cyclically Adjusted PS Ratio is 2.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IVF hartmann Holding AG's current Cyclically Adjusted PS Ratio is 2.04, which is 26% below median its own 10-year median of 2.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IVF hartmann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, IVF hartmann Holding AG (XSWX:VBSN) is currently considered Fairly Valued. The stock's GF Value™ is CHF143.29, compared to a current price of CHF130.50 — trading 8.9% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 2.04, which is 26% below median its 10-year median of 2.77 and 10.5% below the Medical Devices & Instruments industry median of 2.28. IVF hartmann Holding AG's overall GF Score™ is 74/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For IVF hartmann Holding AG (XSWX:VBSN), the current Cyclically Adjusted PS Ratio is 2.04 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IVF hartmann Holding AG (XSWX:VBSN) Overvalued in 2026?
Based on GuruFocus' analysis, IVF hartmann Holding AG stock appears to be undervalued.
The current stock price of CHF130.50 is trading 8.9% below its estimated GF Value™ of CHF143.29.
GuruFocus considers IVF hartmann Holding AG to be Fairly Valued.
Key valuation signals for XSWX:VBSN:
Cyclically Adjusted PS Ratio: 2.04 (26% below median its 10-year median of 2.77)
GF Value™: CHF143.29 vs. price of CHF130.50 (8.9% below fair value)
Industry Position: 10.5% below the Medical Devices & Instruments median (#249 of 523)
No single metric tells the full story. See the XSWX:VBSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.
74GF Score
Get the complete analysis for XSWX:VBSN
Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:VBSN has been successfully added to your 
